Atlas Molecular Pharma (Atlas), a biotechnology company and spin-off of CIC bioGUNE, has closed a €3 million investment round aimed at driving the clinical development of ATL-001, its oral clinical-...
Read moreBIO International Convention San Diego is the must-attend event for any company aiming to compete in the top tier of biotechnology. Every year, this gathering brings together the leading players in th...
Read moreLa estrategia de inversión especializada ha permitido capitalizar el gran potencial de la innovación biomédica, impulsada además por una oleada de fusiones y adquisiciones.
Read moreOriva Therapeutics, a women’s health company developing first-in-class and best-in-class approaches to treat chronic, prevalent conditions affecting women, announced today its incorporation, as well...
Read moreBiorce has closed a $52.5 million investment round (approximately €44.3 million) with the aim of accelerating the development of its artificial intelligence software for clinical trials and strength...
Read moreThe biotechnology company Orikine Bio, recently established at the Barcelona Science Park, has received an investment of €2.7 million from the SICC Innvierte of CDTI Innovación together with the fu...
Read moreSe trata de un programa de screening oportunista dirigido a población general para realizar la determinación de la albuminuria a partir de una muestra de orina, lo que permite detectar precozmente l...
Read moreBiotasmart, a Valencia-based startup specializing in the clinical interpretation of the microbiota, has closed an investment round led by Angels, the investment arm of Juan Roig and part of Marina de ...
Read moreGENESIS Biomed closes 2025 as its best year ever, with strong growth compared to 2024: 506 projects (+26.5%) and 323 customers (+43.6%).
Read moreLa compañía biomédica Aortyx ha sido distinguida con el Premio Catalonia.health 2026 durante la 12.ª edición de La Nit, el encuentro anual de referencia del sector de la salud y las ciencias de l...
Read moreCRB Health Tech SGEIC has announced its investment in Circle Health’s €9 million Seed round, alongside Atlantic, Calm/Storm and Kfund, with the aim of supporting the company’s scaling efforts in...
Read morePharmacelera, a deep tech company applying Quantum Mechanics and Artificial Intelligence to revolutionize drug discovery based at the Barcelona Science Park (PCB-UB), has closed a €6 million investm...
Read more